Lifescan Europe, A Division of Cilag GmbH
SwitzerlandFDA applicant, unverified
- Devices
- 1
What Lifescan Europe, A Division of Cilag GmbH makes
Lifescan Europe manufactures the OneTouch Via, an on-demand insulin delivery system designed for subcutaneous insulin administration, intended for individuals managing diabetes.
The OneTouch Via is classified as a Class II medical device under FDA regulations and is listed via the 510(k) pathway. The manufacturer is based in the United States.
Catalogue
OneTouch Via On-Demand Insulin Delivery System Ref K163357
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Lifescan Europe, A Division of Cilag GmbH have in the registry?
The registry currently lists 1 device for Lifescan Europe, A Division of Cilag GmbH. Devices recorded under merged duplicate company entries are counted once.
Which registries list Lifescan Europe, A Division of Cilag GmbH's devices?
Among its 1 most recently registered device, Lifescan Europe, A Division of Cilag GmbH has devices listed in FDA 510(k) (1 device).
What risk classes do Lifescan Europe, A Division of Cilag GmbH's devices fall under?
Among its 1 most recently registered device, the classes recorded for Lifescan Europe, A Division of Cilag GmbH's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Lifescan Europe, A Division of Cilag GmbH in the registry?
The most recently registered devices listed for Lifescan Europe, A Division of Cilag GmbH include OneTouch Via On-Demand Insulin Delivery System.